[144] ZoomInfo Technologies Inc. SEC Filing

Rhea-AI Filing Summary

ZoomInfo Technologies Inc. (GTM) filed a Form 144 reporting a proposed sale of 87 shares of Common stock through Morgan Stanley Smith Barney, with an aggregate market value of $949.17, scheduled approximately for 10/01/2025. The shares were acquired as Restricted Stock Units on 07/01/2025 and payment/issuance is recorded on the same date. The filing lists total shares outstanding as 318,630,783, indicating the sale represents a de minimis fraction of outstanding equity. The notice also discloses prior 10b5-1 sales by the same account over the past three months: 7,754 shares sold across four transactions on 07/02/2025, 08/01/2025, 09/02/2025 and 09/03/2025 with combined gross proceeds shown in the filing.

Positive

• Filer disclosed broker and exact sale date, supporting transparent execution through Morgan Stanley Smith Barney
• Shares acquired as Restricted Stock Units on 07/01/2025, indicating a standard equity compensation vesting event
• Sale size (87 shares, $949.17) is immaterial relative to 318,630,783 shares outstanding, limiting market impact
• Prior 10b5-1 trades disclosed, suggesting use of prearranged trading plans for insider sales

Negative

• Insider executed multiple 10b5-1 sales in prior months (total 7,754 shares), which may prompt investor questions despite being small relative to outstanding shares

Insights

Financial Analyst

TL;DR: Routine insider sale filing; transaction size is negligible versus market cap and consistent with RSU vesting and 10b5-1 execution.

The Form 144 documents a small proposed sale of 87 shares following acquisition of RSUs on 07/01/2025. With 318.6 million shares outstanding, this disposal is immaterial to capital structure and valuation. The filing appropriately identifies the broker, sale date, acquisition type, and prior 10b5-1 trades, supporting compliance and orderly disposal. From a liquidity and market-impact perspective, such a small lot is unlikely to move the stock price or signal company-level issues. The disclosed prior 10b5-1 sales totaling 7,754 shares show ongoing, preplanned insider monetization but remain minor relative to outstanding shares.

Corporate Governance Expert

TL;DR: Disclosure appears consistent with Rule 144 and 10b5-1 procedures; documentation meets basic compliance expectations.

The filing names the selling account, broker, acquisition method (Restricted Stock Units) and includes the requisite representations about material nonpublic information. The inclusion of prior 10b5-1 sales and explicit date of RSU acquisition aligns with best-practice transparency for insider transactions. No gaps in mandatory fields are apparent in the provided content. This record supports that the insider followed an established plan and filed the requisite notice for proposed sale volume.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	87	949.17	318630783	10/01/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/01/2025	Restricted Stock Units	Issuer			87	07/01/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ASHLEY MCGRANE 330 W Columbia Way, Floor 8 Vancouver WA 98660	COMMON	09/03/2025	286	2925.78
10b5-1 Sales for ASHLEY MCGRANE 330 W Columbia Way, Floor 8 Vancouver WA 98660	COMMON	09/02/2025	453	4711.20
10b5-1 Sales for ASHLEY MCGRANE 330 W Columbia Way, Floor 8 Vancouver WA 98660	COMMON	08/01/2025	4617	47719.34
10b5-1 Sales for ASHLEY MCGRANE 330 W Columbia Way, Floor 8 Vancouver WA 98660	COMMON	07/02/2025	1398	14048.92

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed by ZoomInfo (GTM) report?

The Form 144 reports a proposed sale of 87 shares of Common stock with an aggregate market value of $949.17, scheduled for 10/01/2025.

How were the 87 shares acquired according to the filing?

The filing states the shares were acquired as Restricted Stock Units on 07/01/2025 with the same date listed for issuance/payment.

Who is the broker handling the proposed sale?

The broker named in the filing is Morgan Stanley Smith Barney LLC located at 1 New York Plaza, 8th Floor, New York, NY 10004.

How many shares has the seller disposed of in the past three months?

The filing discloses prior 10b5-1 sales totaling 7,754 shares across transactions on 07/02/2025, 08/01/2025, 09/02/2025 and 09/03/2025.

What is the total number of outstanding shares noted in the Form 144?

The filing lists 318,630,783 shares outstanding.